Publications
- A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR2021 | Second Faculty of Medicine
- Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma2021 | Second Faculty of Medicine
- Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance2021 | Second Faculty of Medicine
- PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum2021 | Second Faculty of Medicine
- Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration2020 | Second Faculty of Medicine
- Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis2020 | Second Faculty of Medicine
- To the Large Nucleolar Bodies in Apoptotic Leukaemic Granulocytic Progenitors without Further Differentiation. Are Large Nucleoli Always Present in Proliferating Cells?2017 | Second Faculty of Medicine
- Potential of histone deacetylase inhibitors (HDACi) in the treatment of paediatric TEL/AML1-positive acute lymphoblastic leukaemia2008 | Second Faculty of Medicine
- Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: A report from the International RRD Consortium2024 | Second Faculty of Medicine
- LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration2024 | Second Faculty of Medicine
Loading network view...